KR840006204A - 벤즈아미도 유도체 및 그제조법 - Google Patents

벤즈아미도 유도체 및 그제조법 Download PDF

Info

Publication number
KR840006204A
KR840006204A KR1019830004251A KR830004251A KR840006204A KR 840006204 A KR840006204 A KR 840006204A KR 1019830004251 A KR1019830004251 A KR 1019830004251A KR 830004251 A KR830004251 A KR 830004251A KR 840006204 A KR840006204 A KR 840006204A
Authority
KR
South Korea
Prior art keywords
compound
formula
chlorine
bromine
applying
Prior art date
Application number
KR1019830004251A
Other languages
English (en)
Other versions
KR900008316B1 (ko
Inventor
드 파우리스 토마스 (외 2)
Original Assignee
베르틸 에릭슨
아스트라 레케메델 악티볼라크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베르틸 에릭슨, 아스트라 레케메델 악티볼라크 filed Critical 베르틸 에릭슨
Publication of KR840006204A publication Critical patent/KR840006204A/ko
Application granted granted Critical
Publication of KR900008316B1 publication Critical patent/KR900008316B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

벤즈아미도 유도체 및 그제조법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (12)

  1. 식 Ⅲ의 화합물을 적용하는 식 Ⅱ의 화합물의 반응에 의하거나 식 C2H5-X 화합물을 적용하는 식 Ⅳ의 화합물의 N-알킬화에 의하거나 식 C2H5NH2화합물을 적용하는 식 Ⅴ의 화합물의 반응에 의하거나 식 Ⅵ의 화합물의 반응에 의하거나 염소/브롬 시약이나 알킬화시약을 적용하는 식 Ⅶ의 화합물의 반응에 의하거나 제1단계로 NaNO22를 적용하고 제2단계로 제1구리할로게나이드(염소/브롬)를 적용하는 식 Ⅷ의 화합물의 반응에 의하거나 식 CH3-B화합물을 적용하는 식 Ⅸ의 화합물의 0-알킬화에 의하거나 식 R-CO-Z' 화합물을 적용하는 식 X의 화합물의 에스테르화에 의해서 식 Ⅰ의 화합물이나 생리학적으로 알맞은 염이나 이들의 광학이성체(이상에서 산출된 화합물은 이들의 생리학적으로 알맞은 염 및/또는 이들의 순수한 입체이성체로됨)를 제조하는 방법.
  2. 여기서, R은 탄소원자가 6-18인 직쇄 또는 측쇄알킬기. R1은 수소, 염소, 브롬 또는 탄소원자가 1-3인 알킬기. R2는 염소, 브롬 또는 탄소원자가 1-3인 알킬기. -CO-Z는 아마성분의 형성하에 아미노기와 반응할 수 있는 반응기. X는 염소, 브롬, 설페이트, 포스페이트, 벤젠설페이트 또는 톨루엔설포네이트, Hal는 염소나크롬. R1'" 및 R2'"는 수소 또는 R1=R2. D1및 D2는 같거나 다른 것으로, 수소원자나 아미노기를 나타내며 이중 적어도 하나는 아미노기. B는 -(SO4)1/2, -(PO4)1/3 또는 할로겐. Z'는 염소나브롬.
  3. 제1항에 있어서, 활성성분으로써 상기 화합물이나 생리학적으로 알맞은 염이나 이들의 광학이성체를 구성하는 제제.
  4. 제2항에 있어서, 일정용량 형태의 제제.
  5. 제2항 내지 제3항에 있어서, 제약학적으로 알맞은 담체와 화합하는 활성성분을 구성하는 제제.
  6. 축적질(depot)제제 형태의 제제.
  7. 피하투여나 근육내 투여용제제.
  8. 제1항에 있어서, 활성성분으로써 식 Ⅰ의 화합물을 구성하는 제제를 제조하기위해 상기 화합물이나 이들의 생리학적으로 알맞은 염을 이용하는 방법.
  9. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830004251A 1982-09-09 1983-09-09 벤즈아미도 유도체의 제조방법 KR900008316B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8205135A SE8205135D0 (sv) 1982-09-09 1982-09-09 Benzamido-derivatives
SE8205135-0 1982-09-09

Publications (2)

Publication Number Publication Date
KR840006204A true KR840006204A (ko) 1984-11-22
KR900008316B1 KR900008316B1 (ko) 1990-11-12

Family

ID=20347777

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830004251A KR900008316B1 (ko) 1982-09-09 1983-09-09 벤즈아미도 유도체의 제조방법

Country Status (30)

Country Link
US (1) US4937260A (ko)
EP (1) EP0117384B1 (ko)
JP (1) JPS5967260A (ko)
KR (1) KR900008316B1 (ko)
AT (1) ATE39482T1 (ko)
BG (1) BG37992A3 (ko)
CA (1) CA1207776A (ko)
CS (1) CS239943B2 (ko)
CY (1) CY1461A (ko)
DD (1) DD211552A5 (ko)
DE (1) DE3378761D1 (ko)
DK (1) DK157846C (ko)
ES (1) ES525488A0 (ko)
FI (1) FI78905C (ko)
GB (1) GB2126585B (ko)
GR (1) GR79666B (ko)
HK (1) HK14589A (ko)
HU (1) HU189745B (ko)
IE (1) IE55907B1 (ko)
IL (1) IL69682A (ko)
MY (1) MY8700304A (ko)
NO (1) NO161853C (ko)
NZ (1) NZ205527A (ko)
PH (1) PH18900A (ko)
PL (1) PL139342B1 (ko)
PT (1) PT77310B (ko)
RO (1) RO86674B (ko)
SE (1) SE8205135D0 (ko)
SU (1) SU1342412A3 (ko)
ZA (1) ZA836280B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8400478D0 (sv) * 1984-01-31 1984-01-31 Astra Laekemedel Ab Oxysalicylamido derivatives
US5240957A (en) * 1984-01-31 1993-08-31 Astra Lakemedel Akteibolag Oxysalicylamido derivatives
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
US5186921A (en) * 1989-04-17 1993-02-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and image agents
US5122361A (en) * 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
US5911970A (en) 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
WO1994026314A1 (en) * 1993-05-06 1994-11-24 John Christy S Compounds for cancer imaging and therapy
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
DK72693D0 (da) * 1993-06-18 1993-06-18 Lundbeck & Co As H Compounds
KR20080055111A (ko) 2006-12-14 2008-06-19 제일모직주식회사 컬러필터용 안료분산액 조성물 및 이를 이용하여 제조된컬러 촬상 소자용 컬러필터

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
BE695272A (ko) * 1967-03-09 1967-09-11
CH507938A (fr) * 1968-08-01 1971-05-31 Ile De France Procédé de préparation de benzamides hétérocycliques
US3793030A (en) * 1971-09-02 1974-02-19 Ricoh Kk Process for producing diazotype light-sensitive material
US3914418A (en) * 1971-09-02 1975-10-21 Merck & Co Inc Methods of controlling liver fluke infections
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
IT1070992B (it) * 1973-12-21 1985-04-02 Italfarmaco Spa Processo per la preparazione della i etil 2 2 metossi 5 sulfamoil benzamidometil pirrolidina
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
CA1039731A (en) * 1974-12-18 1978-10-03 Synthelabo Process for preparing new 2-methoxy-benzamide derivatives
US4029678A (en) * 1975-12-08 1977-06-14 Hoffmann-La Roche Inc. Asymmetric synthesis
JPS5319447A (en) * 1976-08-07 1978-02-22 Igeta Seikou Kk Manufacture of endless wire rope
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
SE411118B (sv) * 1978-03-23 1979-12-03 Astra Laekemedel Ab Ett forfarande for framstellning av 2,6-dialkoxibensamider med terapentiska egenskaper
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
IT1141095B (it) * 1980-11-27 1986-10-01 Ravizza Spa Processo di risoluzione della sulpiride racema
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
JPH0331704A (ja) * 1989-06-29 1991-02-12 Matsushita Electric Ind Co Ltd 位置合わせ装置

Also Published As

Publication number Publication date
JPS5967260A (ja) 1984-04-16
FI833206A0 (fi) 1983-09-07
GR79666B (ko) 1984-10-31
FI78905B (fi) 1989-06-30
ZA836280B (en) 1984-04-25
DK157846C (da) 1990-07-23
IL69682A0 (en) 1983-12-30
GB8324080D0 (en) 1983-10-12
IE832094L (en) 1984-03-09
DK403883D0 (da) 1983-09-06
CY1461A (en) 1989-07-21
DK403883A (da) 1984-03-10
PT77310A (en) 1983-10-01
FI833206A (fi) 1984-03-10
KR900008316B1 (ko) 1990-11-12
JPH0471066B2 (ko) 1992-11-12
HU189745B (en) 1986-07-28
MY8700304A (en) 1987-12-31
IL69682A (en) 1987-12-31
NO833219L (no) 1984-03-12
US4937260A (en) 1990-06-26
HK14589A (en) 1989-02-24
DK157846B (da) 1990-02-26
BG37992A3 (en) 1985-09-16
ATE39482T1 (de) 1989-01-15
EP0117384A1 (en) 1984-09-05
NZ205527A (en) 1986-04-11
DE3378761D1 (en) 1989-02-02
CS636283A2 (en) 1985-05-15
PL139342B1 (en) 1987-01-31
EP0117384B1 (en) 1988-12-28
NO161853B (no) 1989-06-26
RO86674A (ro) 1985-04-17
GB2126585B (en) 1986-04-23
DD211552A5 (de) 1984-07-18
FI78905C (fi) 1989-10-10
CA1207776A (en) 1986-07-15
IE55907B1 (en) 1991-02-14
ES8501748A1 (es) 1984-12-01
RO86674B (ro) 1985-05-01
PL243670A1 (en) 1985-03-12
CS239943B2 (en) 1986-01-16
SE8205135D0 (sv) 1982-09-09
ES525488A0 (es) 1984-12-01
PT77310B (en) 1986-05-19
NO161853C (no) 1989-10-04
GB2126585A (en) 1984-03-28
SU1342412A3 (ru) 1987-09-30
PH18900A (en) 1985-10-30

Similar Documents

Publication Publication Date Title
KR840001156A (ko) 벤지미다졸 유도체의 제조방법
KR840006204A (ko) 벤즈아미도 유도체 및 그제조법
KR870002125A (ko) 피리딘 유도체의 제조방법
DK196686A (da) Quinuclidinderivater
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
PT82682B (pt) Processo para a preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem
KR840004106A (ko) 4급 6,11-디하이드로-디벤조-[b,e]-티에핀-11-N-알킬-노르스코핀 에테르의 제조방법
KR860006464A (ko) 6-티오크산틴 유도체
KR940021059A (ko) 지질 대사 개선제
KR840007596A (ko) 유기인 유도체의염의 제조방법
KR910000730A (ko) N-헤테로아릴-푸린-6-아민, 이의 제조방법 및 약제로서의 이의 용도
KR860700250A (ko) 신규 아미딘 화합물
KR890014523A (ko) 피리미딘유도체, 그것의 제조방법 및 그것을 함유하는 제초조성물
MY103273A (en) Softener for fibers
KR830007092A (ko) 방사성 진단제 및 그의 비-방사성 담체
KR880000461A (ko) 안드로스트-4-엔-3,17-디온 및 그의 제조방법
KR910014380A (ko) 이미자조피리다진 화합물, 그의 제법 및 용도
KR890001969A (ko) 황화합물, 이들의 제법 및 이들을 함유하는 제약학적 조성물
KR870008575A (ko) 모발 화장품
KR830004320A (ko) 퀴나졸린 유도체의 제조방법
KR900700103A (ko) 항-알레르기성 점안제
KR880002868A (ko) 피리도 피리미딘 디온
PT82547B (pt) Processo de preparacao de acidos hexenoicos e de composicoes farmaceuticas que os contem
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee